All News

A look at how to develop a generic drug and the resources FDA supplies to Abbreviated New Drug Application applications.

A review of the current use of real-world data and evidence in HTA and payer appraisals, its potential role in lifecycle management, and how the early dialogue provided by Integrated Scientific Advice engagement can be used as a key tool in the planning and generation of RWE.

Click the title above to open the Pharmaceutical Executive November 2019 issue in an interactive PDF format.

Boasting a long and proud tradition in the life sciences, consistently ranked among the world’s most pioneering countries, Sweden’s biggest task will be to maintain such standards in an era where medical science is becoming ever more sophisticated and integrated with other disciplines.

reviews the two most salient changes in Academy of Managed Care Pharmacy's new Format for Formulary Submissions

Our quest to make sense of a complex future data ecosystem in pharma.

A look at highlights from the Digital Pharma East conference looking at technology and marketing innovation in pharma.

Leela Barham reacts to the Institute for Economic and Clinical Review's very first Unsupported Price Increase (UPI) report.

Click the title above to open the Pharmaceutical Executive October 2019 issue in an interactive PDF format.

After two decades of building a robust healthcare ecosystem, Thailand is seeking to move to the next level-Thailand 4.0-a potential stepping stone in its strategy to initiate a transformative era with a greater embrace of R&D.

A look into how native advertising works, what cost benefits they provide, and measuring their success.